# Glasdegib Absolute Bioavailability Study

> **NCT03270878** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Glasdegib Oral Tablet
- **DRUG:** Glasdegib IV infusion

## Key facts

- **NCT ID:** NCT03270878
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-07
- **Primary completion:** 2017-10-06
- **Final completion:** 2017-10-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03270878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03270878, "Glasdegib Absolute Bioavailability Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03270878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*